Skip to main content
Account

Peer review reports

From: Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors

Original Submission
7 Oct 2019 Submitted Original manuscript
4 Dec 2019 Reviewed Reviewer Report
11 Dec 2019 Reviewed Reviewer Report
12 Dec 2019 Reviewed Reviewer Report
19 Feb 2020 Author responded Author comments - Svenja Wagener-Ryczek
24 Feb 2020 Reviewed Reviewer Report
6 Mar 2020 Reviewed Reviewer Report
24 Mar 2020 Author responded Author comments - Svenja Wagener-Ryczek
Resubmission - Version 2
19 Feb 2020 Submitted Manuscript version 2
31 Mar 2020 Reviewed Reviewer Report
17 Apr 2020 Reviewed Reviewer Report
29 Apr 2020 Author responded Author comments - Svenja Wagener-Ryczek
Resubmission - Version 3
29 Apr 2020 Submitted Manuscript version 3
Publishing
30 Apr 2020 Editorially accepted
12 May 2020 Article published 10.1186/s12885-020-06920-3

Learn about peer review

Back to article page

Navigation